In partnership with
Here’s what’s happening in the stock market today:
The stock market is showing modest gains today as Wall Street futures rebound on oil retreat and investors weigh US-Iran tensions, with chip stocks stabilizing after recent weakness. 📈🚀 Futures tied to the S&P 500 rose 0.54%, Nasdaq 100 gained 0.54%, while Dow futures edged 0.02% higher. Nvidia climbed 3.66%, Cisco Systems +1.94%, Walmart +1.41% among gainers. Chip stocks rebounded after tariff concerns, with earnings season kicking off. Gold near $3,146, oil at $69-70/barrel. Treasury yield at 4.44%. Fed expected to hold in July, hike in September on 4% inflation. Investors await Q2 earnings for rally strength amid tech bubble concerns. 🛢️💰
Major Indices Performance (July 8 Close) 📊
S&P 500 rose 0.54%, closing at 7,522.76 (+40.05 pts), building on best quarter since 2020.
Dow Jones Industrial Average gained 0.02%, closing at 52,348.39 (+9.17 pts), cyclical support steady.
Nasdaq Composite surged 0.54%, closing at 25,870.65 (+51.96 pts), chip rebound led tech gains.
Market Movers 🚀
Nvidia jumped 3.66%, Cisco Systems +1.94%, Walmart +1.41% among tech/consumer gainers.
Chip stocks rebounded after recent weakness, with AMD and Nvidia gaining on improved outlook.
American Express fell 3.79%, Sherwin-Williams -3.40%, Boeing -2.96% among cyclical laggards.
Gold near $3,146, oil at $69-70 on Middle East tensions easing.
Tech megacaps (Microsoft, Apple) recovered early pressure, boosting Nasdaq.
Key Events Driving the Market 🗞️
US-Iran tensions persist: Trump said Iran deal is "over," but oil steadied as diplomatic hopes linger.
Chip stocks rebounded after tariff concerns, with earnings season kicking off later this week.
Fed expected to hold in July, hike in September after 4% inflation; job data fuels rate hike fears.
Earnings season starts later this week: Investors seek early signs of rally strength amid tech bubble concerns.
Tech bubble fears persist, stoked by soaring valuations, trillion-dollar swings, and sharp selloffs.
Investor Sentiment 👀
Overall, mood is cautiously optimistic as chip rebound and tech gains outweigh cyclical declines. Volatility from tech swings; investors await Q2 earnings for rally strength amid tech bubble concerns. 🐂⚖️
Elon's Launching His Own "iPhone." 3 Stocks to Buy to Prepare
If you'd bought Apple before the first iPhone, you'd have seen peak gains of 7,537%. One product turned ordinary investors into millionaires.
Now Elon Musk is launching his own version — a device he claims will be "10x bigger than the largest product in history."
Target launch: July 22. Just days away.
The people who win on launches like this don't buy after the headlines. They position before. Our analyst pinpointed 3 stocks set to ride the launch — with entry guidance and price targets, plus a bonus 4th pick (the most undervalued name in the supply chain) and a 3-phase playbook showing exactly when to buy, when to add, and when to take profits.
100% free. No credit card. Over 2,500 investors have already read it.
TRADE OF THE DAY:
AXON
Name: Axon Enterprise, Inc.
Symbol: AXON
Current Price: Approximately $584.08
Trade
Sell to Open: 1 AXON Jul 31, 2026 490/485 Put Vertical
Total Credit Received: $70.00
Credit per Contract: $70.00 (for one contract covering 100 shares)
Direction: Bullish (expects AXON to stay above the break-even level)
Probability of Profit (PoP): 84.2% (as provided)
Potential ROI:
Max Risk (Loss): $430.00
ROI: ($70.00 ÷ $430.00) × 100 ≈ 16.3%
Trade Explained in Simple English:
You’re entering a bullish put credit spread by selling the $490 put and buying the $485 protective put, both expiring on July 31, 2026. You receive $70.00 upfront, and the trade profits if AXON stays above the $489.30 break-even price at expiration. Your maximum profit is limited to the $70.00 credit received, while your maximum loss is capped at $430.00 if AXON finishes below $485.00 at expiration.
Wall Street Highlights:
News Beyond the Numbers
PepsiCo topped quarterly sales and profit estimates, but warned of higher input cost inflation later this year as its North American business remained softer than expected. Read More
AstraZeneca and Ionis Pharmaceuticals suffered a setback after their late-stage heart disease treatment failed to meet its primary goal in clinical trials. Read More
SK Hynix's highly anticipated U.S. listing is drawing exceptional investor demand, with reports indicating the offering is heavily oversubscribed amid continued AI memory optimism. Read More
Levi Strauss raised its full-year earnings outlook after beating quarterly expectations, even as investors focused on its cautious guidance. Read More
Salesforce came under pressure after a KeyBanc analyst downgrade raised concerns about the company's near-term outlook, weighing on other software names as well. Read More
Disclaimer: The content provided by OptionPicks is for informational and educational purposes only and should not be construed as investment, financial, legal, or tax advice. We are not registered as a broker-dealer, investment adviser, or financial advisor with the SEC, FINRA, or any other regulatory authority. Options trading involves substantial risk and is not suitable for every investor. Past performance is not indicative of future results, and no representation is being made that any subscriber will or is likely to achieve profits or incur losses similar to those mentioned. You should consult with a licensed financial professional before making any investment decisions.
